Target intelligence / Profile preview

Telomere maintenance

Molecular classification
Other
01

Overview

Telomere maintenance refers to the process by which cells preserve the length and integrity of telomeres—repetitive DNA–protein structures at the ends of linear chromosomes[1][4][7]. This homeostatic mechanism primarily depends on the reverse transcriptase enzyme telomerase, which synthesizes telomeric repeats, and a specialized protein complex known as shelterin that protects chromosome ends and regulates access to telomerase[1][2][3][4][6]. Additional regulatory layers include epigenetic modifications and DNA damage response pathways[1][4][7]. Proper telomere maintenance is vital for chromosome stability, sustained cell division, and prevention of genomic instability. Disruption in telomere maintenance is implicated in cancer (where maintenance is often upregulated to allow unlimited division), premature aging syndromes, and degenerative diseases[2][5][8]. Dysfunction may arise from inherited mutations in telomerase or shelterin complex genes. Drugs do not typically interact with "telomere maintenance" as a single target; rather, compounds may modulate components of this system, such as telomerase inhibitors (e.g., imetelstat) or, experimentally, drugs targeting shelterin proteins or related pathways. Thus, telomere maintenance itself is not a discrete biomolecular entity but an ensemble process and regulatory network[1][2][7][10].

Other names
Telomere length maintenanceTelomere stabilizationTelomere homeostasis
02

Biological functions

Chromosome end protectionGenome stabilityRegulation of cell cyclePrevention of cellular senescenceRegulation of apoptosisDNA repair regulation
03

Disease associations

CancerAgingTelomere biology disorders (e.g., dyskeratosis congenita)Cardiovascular diseaseNeurodegenerative disease
04

Safety considerations

Excessive telomere shortening: cellular senescence, aging, tissue dysfunctionTelomerase activation: risk of cancer due to unrestricted cell proliferationPotential for telomere dysfunction syndromes (e.g., bone marrow failure)
05

Biomarkers

Telomere lengthTelomerase activity

Beyond the preview

Go deeper on Telomere maintenance.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Telomere maintenance.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call